ACS Chemical Neuroscience · 2019 · 37 citations · 40 references
Life SciencesNeurosciencePharmacologyMolecular NeurobiologyMolecular NeuroscienceNeuropharmacologyAlzheimer DiseaseMolecular Basis Of NeurodegenerationNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationDual-target InhibitorsEpoxide Hydrolase ActivityEpoxide Hydrolase PathwaysNeuroinflammation In Alzheimer DiseaseNeuroinflammation-driven Cell DeathNeurotoxicityP38 Mitogen-activated Protein Kinase SignalingPharmacological Therapy
Alzheimer’s disease (AD) is the most common neurodegenerative disorder. Neuroinflammation is a prevalent pathogenic stress leading to neuronal death in AD. Targeting neuroinflammation to keep neurons alive is an attractive strategy for AD therapy. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) is a potent inhibitor of soluble epoxide hydrolase (sEH) and can enter into the brain. It has good efficacy on a wide range of chronic inflammatory diseases in preclinical animal models. However, the anti-neuroinflammatory effects and molecular mechanisms of TPPU for potential AD interventions remain elusive. With an aim to develop multitarget therapeutics for neurodegenerative diseases, we screened TPPU against sEH from different mammalian species and a broad panel of human kinases in vitro for potential new targets relevant to neuroinflammation in AD. TPPU inhibits both human sEH and p38β kinase, two key regulators of inflammation, with nanomolar potencies and distinct selectivity. To further elucidate the molecular mechanisms, differentiated SH-SY5Y human neuroblastoma cells were used as an AD cell model, and we investigated the neuroprotection of TPPU against amyloid oligomers. We found that TPPU effectively prevents neuronal death by mitigating amyloid neurotoxicity, tau hyperphosphorylation, and mitochondrial dysfunction, promoting neurite outgrowth and suppressing activation and nuclear translocation of NF-κB for inflammatory responses in human nerve cells. The results indicate that TPPU is a potent and selective dual inhibitor of sEH and p38β kinase, showing a synergistic action in multiple AD signaling pathways. Our study sheds light upon TPPU and other sEH/p38β dual inhibitors for potential pharmacological interventions in AD.
40
Lotta Agholme, Tobias Lindström, Katarina Kågedal et al. · Journal of Alzheimer s Disease · 2010 · 504 citations · Full text
Methods for High-throughput Drug Combination Screening and Synergy Scoring
Liye He, Evgeny Kulesskiy, Jani Saarela et al. · Methods in molecular biology · 2018 · 263 citations · Full text
Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors
Sung Hee Hwang, Hsing‐Ju Tsai, Jun‐Yan Liu et al. · Journal of Medicinal Chemistry · 2007 · 227 citations · Full text
Nicola Origlia, Massimo Righi, Simona Capsoni et al. · Journal of Neuroscience · 2008 · 199 citations · Full text